Home » Balancing Aromatase Inhibitors and Coffee: Side Effects, Myths & Practical Tips

Balancing Aromatase Inhibitors and Coffee: Side Effects, Myths & Practical Tips

Jacob Yaze

November 7, 2025

OneHundredCoffee is reader-supported, and some products displayed may earn us an affiliate commission. Details

How Aromatase Inhibitors Aid In Reducing Estrogen Levels For Breast Cancer Patients

Aromatase inhibitors—anastrozole, letrozole, exemestane—do one essential job: they dial down estrogen production so treatment plans for hormone-receptor–positive breast cancers can work with a steadier, quieter background. Coffee, on the other hand, is the daily ritual many of us don’t want to lose—the comfort, the aroma, the lift of a small cup that helps the morning settle into focus. The aim isn’t to pick one or the other. It’s to set up a routine where your medicine continues to do its reliable work while your coffee remains something you enjoy, not something you manage.

A few gentle principles carry significant weight. First, pair the cup with food. A light snack or breakfast buffers acidity and softens the “rush” some people feel with fast, hot, caffeinated drinks. Second, go small and steady. One giant mug on an empty stomach is more likely to trigger reflux, jitters, or light-headedness than two smaller cups, spaced and savored. Third, consider the brew. Paper-filtered drip or pour-over often feels smoother than unfiltered methods; a diluted cold brew can be even gentler on days when the stomach is fussy, or sleep has been fragile. Finally, choose beans that love you back—low-acid decaf or half-caff blends keep the comfort while trimming the edges that can make you feel “on the edge.”

Hydration helps more than people expect. If you notice wooziness when you stand up—or a racing heart after a fast espresso—treat it like a “calm the system” moment: add water, slow the sip, and move the cup to the side or after your meal. If you want the water habit to feel automatic instead of “one more thing,” keeping a bottle you actually like using nearby helps a lot—something like the Takeya Sport Insulated Water Bottle makes it easy to sip consistently without thinking. And if you’re in a phase where you feel extra dry (hot weather, dry clinic air, long workdays), a gentle electrolyte option can make hydration feel more effective than plain water alone for some people—Nuun Sport Electrolyte Tablets is one example people keep in the bag for “just in case” days.

If sleep is precious (it always is), make caffeine boring on purpose: park the last caffeinated cup in the early afternoon, then keep the late-day ritual decaf so you still get the aroma and comfort without tugging on bedtime. A cozy, smooth decaf like Mayorga Organics Decaf Café Cubano can make that evening cup feel like a treat rather than a downgrade. And if you’re working through joint aches or hot flashes, a calmer coffee—smaller, gentler, low-acid—often makes the whole day feel easier. A low-acid choice like Lucy Jo’s Organic Low Acid Coffee (Mellow Belly) can be a good “comfort coffee” lane when reflux or sensitivity is flaring.

Personalization is the quiet superpower. Watch your own signals for two weeks—energy, sleep, reflux, and how your mornings feel. You’ll spot patterns quickly: maybe a small paper-filtered cup with breakfast is perfect, while a big latte before food isn’t. If you want a super consistent, gentle brew that’s easy to repeat (especially when you’re trying to learn your pattern), a brewer like the Clever Coffee Dripper makes “small, smooth, predictable” basically automatic. Keep what works; adjust what doesn’t. The goal is a routine you barely think about—where your aromatase inhibitor is doing its job quietly in the background, and your cup still feels like you.

Below is a quick, at-a-glance table for the most common AIs. It highlights how coffee may feel with each, easy guidance, a simple timing nudge, and a “safest beans” pick centered on low-acid/decaf or half-caff profiles.

*“Safest beans” = typically low-acid, decaf, or half-caff options that many readers find gentler on reflux, sleep, and day-to-day steadiness. Personalize to your own tolerance and clinician advice.

Exploring The Potential Of Coffee As A Source Of Aromatase Inhibitors

If you live with, treat, or worry about hormone-sensitive breast cancer, the word aromatase quickly becomes part of your everyday vocabulary. Aromatase (CYP19) is the enzyme that converts androgens into estrogens. Modern aromatase-inhibitor medicines—such as anastrozole, letrozole, exemestan, and the older drug testolactone—work by blocking this enzyme so the body makes far less estrogen, which in turn slows the growth of estrogen-receptor-positive (ER+) breast cancers.

It’s fascinating that nature produces its own, gentler aromatase inhibitors. A major review of natural compounds affecting aromatase points to many plant-based polyphenols—like flavonoids, lignans, coumestans, and similar substances—as mild CYP19 inhibitors. While they don’t replace prescription drugs, they suggest that diet can gently positively influence estrogen biology.

Coffee belongs squarely in that conversation. Dietitians writing for Bezzy Breast Cancer note that black tea, green tea, coffee, and cocoa have “very high aromatase-inhibitor activity” compared with many other foods. A separate review of natural aromatase inhibitors aimed at clinicians echoes this, pointing out that polyphenol-rich beverages such as coffee, cocoa, and green tea “strongly inhibit aromatase.”

Why might this matter? Several large observational studies and meta-analyses suggest that women who drink coffee regularly—particularly postmenopausal women—have a slightly lower risk of developing breast cancer compared with non-drinkers. In one meta-analysis, each extra two cups of coffee per day was associated with about a 2% reduction in breast cancer risk overall, and up to a 10% reduction in postmenopausal women drinking four cups a day. Researchers speculate that aromatase inhibition by coffee polyphenols, along with increased sex-hormone-binding globulin (SHBG) and improved estrogen metabolism, could explain part of this modest benefit.

It’s important to keep expectations grounded. The effect size from coffee alone is small compared with what you get from prescription aromatase inhibitors such as Arimidex® (anastrozole), Femara® (letrozole), and Aromasin® (exemestane), which can drive estrogen levels down to almost undetectable ranges. But for many women, especially those already on endocrine therapy, it’s reassuring to hear that their morning cup is unlikely to “feed” their cancer—and may gently support the same hormonal direction their medication is taking.

So when we talk about coffee as a “source of aromatase inhibitors,” we’re not saying a latte is a replacement for anastrozole. We’re saying that inside each cup lies a cocktail of plant compounds nudging estrogen-producing pathways in the right direction. For someone living with or at risk of ER+ breast cancer, that can turn an everyday habit into a small act of self-care—provided it’s discussed with the oncology team and fitted sensibly into the bigger treatment plan.

Unveiling The Phytochemicals In Coffee: Nature’s Aromatase Inhibitors

It’s easy to think of coffee as “just caffeine,” but chemically it’s much closer to a complex herbal extract. A typical cup contains hundreds of bioactive compounds, including chlorogenic acids, caffeic acid, ferulic acid, trigonelline, melanoidins, and diterpenes such as cafestol and kahweol. Many of these belong to the large family of polyphenols, a group of plant chemicals famous for antioxidant and anti-cancer actions.

Polyphenols and related phytochemicals can modulate carcinogenic signalling pathways, damp inflammation, trigger cancer-cell death, and, crucially for breast cancer, interfere with estrogen synthesis. Experimental work shows that a variety of flavonoids and other phenolics can inhibit aromatase (CYP19), the same enzyme targeted by drugs like letrozole and exemestane. While many of these studies used tea or grape-derived polyphenols, the principle carries over to coffee, which is equally rich in these structures.

Some clues are quite direct. Reviews on diet and aromatase note that beverages high in polyphenols—coffee, cocoa, green and black tea—can “strongly inhibit aromatase” activity in vitro. In postmenopausal women, higher coffee intake has been associated with lower circulating estrogens and higher SHBG, implying that coffee’s phytochemicals are nudging hormone metabolism at a systemic level.

Chlorogenic acids, abundant in both regular and decaf coffee, may be particularly important. They have been shown to modulate cytochrome P450 enzymes and influence steroid metabolism in ways that could reduce estrogen availability to breast tissue. Caffeine itself can also change estrogen and SHBG levels, although its effects are complex and seem to vary by menopausal status and genetic differences in caffeine metabolism.

Of course, a petri dish is not a person. The concentrations of polyphenols used in cell-culture experiments are often higher than what you’d ever reach from diet alone. And when you drink coffee, these compounds undergo digestion, metabolism, and liver processing before reaching your breast tissue. That’s why clinicians view them as adjunctive, not primary, aromatase inhibitors. Still, they form part of a consistent picture: diets rich in varied polyphenols—coffee, tea, berries, herbs, vegetables—appear to support healthier estrogen signalling and may modestly reduce breast-cancer risk over a lifetime.

So the magic in your mug isn’t only the caffeine hit. It’s the quiet, daily exposure to a spectrum of phytochemicals that whisper “less estrogen, more balance” to your cells. When layered on top of standard oncologic care, that whisper may contribute to a slightly more favourable hormonal environment—without the side-effect burden of adding yet another pill.

The Promising Link Between Coffee Consumption And Reduced Breast Cancer Risk

For years, patients have asked their oncologists the same anxious question: “Does my coffee habit make breast cancer more likely—or less?” The honest answer is nuanced, but increasingly reassuring.

A comprehensive narrative review by Nehlig in 2021 concluded that in the general population, coffee intake is associated with either no change or a slight reduction in breast cancer risk, even at high consumption levels. When researchers zoomed in on specific groups, the pattern became more interesting: coffee appeared inversely associated with breast cancerrisk in postmenopausal women and in women carrying BRCA1 mutations.

Several meta-analyses back this up. One dose–response analysis pooling 20 case-control and 17 cohort studies found that breast cancer risk dropped by about 2% for every additional two cups of coffee per day, with a relative risk around 0.97 for the highest vs. lowest intake categories. A more recent meta-analysis from Li and colleagues in Annals of Palliative Medicine updated the data again and confirmed a weak but statistically significant negative correlation between coffee intake and breast cancer risk overall (RR 0.95; 95% CI 0.92–0.99). In their subgroup analysis, the protective association was clearest in postmenopausal European women, and they estimated that four cups a day could reduce risk by roughly 10% in that group.

Other large prospective cohorts, such as those involving tens of thousands of women followed for years, come to similar conclusions: no increase in risk, and possible modest risk reductions for certain subtypes or in specific populations. There’s also emerging evidence that high coffee consumption may lower the risk of other estrogen-sensitive cancers, such as endometrial cancer, again hinting at a common hormonal mechanism.

How might coffee confer this small advantage? Several mechanisms are being explored:

• Aromatase inhibition and estrogen reduction. Polyphenols in coffee appear to modestly inhibit aromatase (CYP19) and may lower circulating estradiol, especially in postmenopausal women.
• Higher SHBG (sex-hormone-binding globulin). Higher caffeine intake has been linked to higher SHBG levels, which bind estradiol and reduce the free fraction capable of stimulating breast cells.
• Anti-inflammatory and antioxidant effects. Coffee polyphenols help neutralise oxidative stress and modulate signalling pathways involved in inflammation and cell proliferation, which are central to carcinogenesis.

Of course, observational data can’t eliminate confounding factors: coffee drinkers may differ from non-drinkers in exercise, diet, weight, smoking, or alcohol habits. But researchers carefully adjust for many of these and still see the modest protective pattern.

For someone already facing a diagnosis of ER+ breast cancer, these numbers don’t mean coffee is a cure or a substitute for medication. Rather, they suggest that moderate coffee consumption—say one to four cups of mostly unsweetened coffee per day—is unlikely to harm and may gently support long-term risk reduction, particularly after menopause. As always, any individual decision should factor in other conditions (like reflux, arrhythmia,,s or anxiety) where caffeine might be less friendly.

Harnessing The Power Of Phytochemicals: Coffee’s Potential As An Adjunct Therapy For Breast Cancer

The word “adjunct” is key here. Oncologists don’t prescribe cappuccinos instead of Arimidex®, Fema,ra®, or Aromasin®, but they are increasingly aware that diet and lifestyle can complement endocrine therapy in meaningful ways. Polyphenol-rich foods and drinks, including coffee, sit right at that intersection.

A broad literature on dietary polyphenols shows that these compounds can influence multiple hallmarks of cancer: they can slow cell proliferation, promote apoptosis (programmed cell death), suppress angiogenesis, reduce inflammation, and modulate epigenetic marks. Some polyphenols also directly inhibit aromatase and 17β-hydroxysteroid dehydrogenase, thereby lowering estrogen production. Reviews in Molecules and other journals discuss how polyphenols from tea, grapes, and other plants can be combined with standard therapies to potentially enhance efficacy and reduce side effects.

Where does coffee fit into this? Emerging clinical work suggests that polyphenol-rich coffee consumption may improve outcomes in women already receiving hormone therapy. In one Swedish study of tamoxifen-treated women, higher coffee intake was associated with significantly fewer early breast-cancer events compared with low intake, and coffee drinkers showed a different pattern of hormone-receptor status in their tumours. The authors speculated that coffee constituents might interact with tamoxifen’s mechanisms or with estrogen signalling pathways in breast tissue.

Another angle involves metabolic and inflammatory health. Coffee drinking has been linked to lower leptin levels, better insulin sensitivity, and reduced chronic inflammation—all factors that influence breast cancer progression and recurrence. Polyphenols in coffee may help tune signalling cascades that are often dysregulated in cancer cells, including PI3K/Akt, MAPK, and NF-κB pathways.

Still, there are limitations. Many polyphenol studies are preclinical; human trials often use concentrated extracts rather than real-life beverages, and individual bioavailability varies widely. Too much coffee, especially loaded with sugar and cream, can also aggravate reflux, anxiety, or heart issues. And we must be clear: the survival benefits from established endocrine therapies dwarf anything coffee might add.

So how might we use this information in a practical, human way?

• See coffee as one piece of a larger plant-rich, Mediterranean-leaning dietary pattern, not a magic bullet.
• Aim for mostly black or lightly sweetened coffee to avoid counteracting potential benefits with excess sugar and saturated fat.
• If you are on aromatase inhibitors or tamoxifen, discuss your coffee intake frankly with your oncology team. In most cases, moderate consumption is acceptable and may be gently supportive, but personalised advice always wins.

Think of coffee phytochemicals as tiny teammates cheering alongside your prescribed aromatase inhibitor—never replacing it, but potentially making the overall field just a bit less favourable to cancer cells.

Coffee and Anastrozole

Anastrozole, best known under the brand Arimidex®, is a third-generation non-steroidal aromatase inhibitor widely used as adjuvant therapy for postmenopausal women with hormone-receptor-positive breast cancer. It blocks aromatase irreversibly, slashing estrogen production and reducing recurrence risk when taken for five years or longer.

Many people taking anastrozole also have a strong relationship with coffee. So how do the two coexist?

From a pharmacokinetic standpoint, no major drug-drug interaction between anastrozole and caffeine has been documented in standard interaction checkers. That means coffee does not appear to dramatically change anastrozole blood levels or vice versa. Instead, the interplay is more about symptoms and overlapping effects.

Anastrozole commonly causes hot flushes, sweating, joint aches, fatigue, and sleep disturbances, very similar to a strong, sudden menopause. Cancer Care Ontario’s patient sheet on anastrozole suggests that people struggling with hot flushes may find it helpful to avoid triggers such as spicy foods, alcohol, and caffeine (tea, coffee, soft drinks). For some women, coffee—especially very hot or caffeinated coffee—can indeed intensify flushes, palpitations, or night sweats.

On the flip side, the Bezzy Breast Cancer nutrition article points out that coffee itself has high natural aromatase-inhibitor activity, thanks to its polyphenols, and that many oncologists are comfortable with moderate coffee intake alongside drugs like anastrozole. Caffeine and coffee intake have also been associated with beneficial changes in SHBG and estrogen metabolism, which conceptually align with anastrozole’s goals.

So, practically speaking:

• You don’t need to abandon Arimidex® + morning coffee unless your team specifically advises it. Many women happily enjoy one to three cups per day during treatment.
• If hot flushes, insomnia, or palpitations are severe, experiment with:
  • Switching to cooler or iced coffee, which may be less triggering than very hot drinks.
  • Choosing half-caf or decaf later in the day.
  • Keeping caffeine mostly before noon to protect sleep.
• Remember that unsweetened or lightly sweetened coffee is preferable; high-sugar coffee drinks can aggravate weight gain and metabolic issues, which are themselves linked to breast cancer recurrence.

Popular anastrozole brands around the world include Arimidex® and multiple generics simply labelled “anastrozole 1 mg.” Regardless of brand, the core message is the same: coffee does not replace your pill, but with some timing tweaks, it can often live happily alongside it, adding a little phytochemical support without worsening side effects.

Coffee and Letrozole

Letrozole, sold under the brand name Femara® and widely available as a generic, is another third-generation aromatase inhibitor. It is often prescribed for postmenopausal ER+ breast cancer and, at lower doses, for ovulation induction in fertility treatment.

The question patients ask most is simple: “Can I drink coffee while taking letrozole?”

A recent practical guide on foods and letrozole from Bezzy Breast Cancer answers that quite directly: yes, you can have caffeine in coffee, tea, or other forms while taking letrozole, as long as it’s in moderation. However, they note that insomnia is a recognised side effect of letrozole, so it can be wise to avoid caffeine later in the day if sleep becomes an issue.

Other sources aimed at fertility patients echo this nuance. The pharmacogenetics platform Xcode explains that letrozole can cause difficulty sleeping and that coffee or other caffeinated drinks may aggravate those symptoms; they recommend avoiding coffee in the afternoon and evening in people who notice sleep disruption. Aspect Health, discussing letrozole as a fertility treatment, similarly advises that if sleep becomes difficult, limiting caffeinated drinks like coffee and tea can help.

On the potential upside, coffee’s polyphenols again come into play. The same articles that highlight coffee as a strong natural aromatase inhibitor note that this effect could theoretically complement letrozole’s pharmacologic suppression of estrogen, particularly in postmenopausal women. There is no evidence, however, that coffee boosts letrozole’s effectiveness enough to change dosing or outcomes; the clinical trials that established Femara®’s benefits did not depend on coffee consumption.

Real-world suggestions if you’re on letrozole and enjoy coffee:

• Aim for steady, moderate intake—for example, one to three standard cups per day rather than big swings from zero to six.
• If you’re waking in the night or feeling “tired but wired,” move your last caffeinated drink earlier in the day or try decaf later on.
• Watch for hot flushes or palpitations; some women find these intensify with coffee, while others feel no difference. Listening to your own body is key.
• Keep an eye on weight and bone health; letrozole can reduce bone density, so pairing it with a generally healthy lifestyle—including a balanced diet, movement, and sensible coffee habits—matters as much as any single beverage.

In short, for most people, Femara® plus morning coffee is a workable pairing. Just avoid using coffee to push through severe fatigue or insomnia without discussing these symptoms with your oncologist—sometimes they signal a need to adjust the treatment plan itself.

Coffee and Exemestane

Exemestane, branded most famously as Aromasin®, is a steroidal aromatase inhibitor that irreversibly inactivates the aromatase enzyme. It’s often used after tamoxifen or as upfront adjuvant therapy in postmenopausal ER+ breast cancer patients.

Exemestane’s side-effect profile overlaps with other AIs—hot flashes, sweating, joint pain, fatigue, and mood changes. Several respected cancer agencies specifically mention caffeine when advising patients how to manage these symptoms.

The BC Cancer Agency’s patient handout recommends, for troublesome hot flashes, “avoiding alcohol, spicy food, caffeine intake (coffee, tea, colas, chocolate)” as part of lifestyle strategies. Cancer Care Ontario gives nearly identical advice: avoiding triggers such as spicy food, alcohol, and caffeine may help some people. Cleveland Clinic’s online drug monograph similarly notes that if hot flashes or sweating are problematic, cutting back on caffeine may provide relief.

This doesn’t mean that caffeine directly interferes with exemestane’s pharmacologic action on aromatase. Rather, coffee is being called out as a symptom trigger: its stimulant and vasodilatory effects can intensify hot flashes, palpitations, and sleep disruption that women are already coping with from estrogen deprivation. For some, one strong espresso can feel like adding fuel to that fire.

At the same time, coffee’s inherent aromatase-inhibitor and antioxidant properties conceptually align with Aromasin®’s goals. There is no robust clinical evidence that drinking coffee undermines exemestane’s effectiveness—in fact, the modest protective association between coffee and breast cancer risk in postmenopausal women suggests compatibility rather than conflict.

If you’re taking exemestane:

• Monitor how your own body reacts to coffee. Some women can happily manage one or two morning cups; others notice dramatic worsening of flushes or insomnia and choose decaf or herbal alternatives.
• Consider trialling a two-week caffeine reduction to see whether joint pain, sweats, or fatigue improve—then decide whether the trade-off is worth it.
• Make sure you’re supporting bone and cardiovascular health with adequate calcium/vitamin D, resistance exercise, and smoking cessation; these strategies often matter more than fine-tuning coffee intake.

Popular exemestane brands include Aromasin® and multiple generics. Whatever the label, remember that coffee is best treated as a flexible companion, not a fixed requirement. Adjust it to feel as good as you can throughout your AI journey.

Coffee and Testolactone

Testolactone is a bit of a historical figure in the aromatase-inhibitor family. Marketed as Teslac®, it was one of the very first aromatase inhibitors used clinically for breast cancer in the 1970s. Structurally related to testosterone, it irreversibly inhibits aromatase and was used for advanced breast cancer and certain endocrine disorders, though it has largely been replaced by newer agents like anastrozole, letrozole, and exemestane due to better potency and tolerability.

Because testolactone is rarely used today, there is little modern research on its interactions with coffee. Standard pharmacology sources focus on its steroid-like structure and side effects (nausea, vomiting, virilisation at high doses) rather than diet interactions; caffeine is not singled out as a major concern.

However, the same general principles that apply to newer AIs can guide anyone still on testolactone:

• Watch for hot flashes, sweating, mood changes, and sleep disturbance, which can be magnified by caffeine.
• Consider that coffee itself exerts mild aromatase-inhibiting and SHBG-raising effects; while this won’t replace Teslac®, it suggests that moderate coffee intake is unlikely to be hormonally counter-productive.
• Because testolactone is a steroidal agent, liver function and lipid profiles may be monitored; extremely high coffee intake can also influence liver enzymes and lipids, so it’s sensible to keep coffee at reasonable, consistent levels, particularly in people with pre-existing liver disease.

If you do happen to be on testolactone—for example, in certain endocrine disorders or in regions where it is still available—your endocrinologist or oncologist is your best guide. There is no clear evidence that you must avoid coffee, but tailoring your intake around your own symptoms and lab findings is always wise.

Clinical Trials And Research Findings: Evidence Supporting Coffee’s Role In Breast Cancer Treatment

Finally, what does the big picture look like when we pull together epidemiology, lab work, and patient-level data?

On the population level, multiple meta-analyses show that coffee is either neutral or slightly protective for breast cancer incidence. Li et al.’s 2021 meta-analysis reported an overall relative risk of 0.95 for high vs. low coffee consumption, with especially clear protection in postmenopausal women and in European cohorts. Lafranconi’s earlier analysis found that four cups daily could reduce postmenopausal breast cancer risk by about 10%. Other cohorts, including Black women in the US, found no harm and hinted at benefit in specific subgroups.

On the mechanistic front, lab and animal studies demonstrate that coffee’s polyphenols:

• Inhibit aromatase (CYP19) and estrogen synthesis in breast cancer models.
• Modulate SHBG, estrogen metabolites, and cytochrome P450 enzymes involved in estrogen metabolism.
• Exert anti-proliferative and pro-apoptotic effects on cancer cells, including liver and breast cancer lines, at physiologically relevant concentrations.

Clinically, coffee has been linked with better outcomes in women already receiving therapy. The Swedish study in tamoxifen-treated patients found that moderate to high coffee consumption correlated with fewer early breast-cancer events and shifts in hormone-receptor status, although causality can’t be assumed. We don’t yet have similarly detailed outcome data for women on aromatase inhibitors like Arimidex®, Femara®, Aromasin®, or Teslac®, but there is no signal of harm at typical consumption levels.

As for polyphenols more broadly, several clinical trials are testing extracts such as green tea catechins, resveratrol, and curcumin alongside standard endocrine therapies. Early results suggest potential improvements in biomarkers and quality of life, but the field is you, ng and trials are often small.

When you put all of this together, a reasonable, patient-centred message emerges:

• Coffee is not a stand-alone breast cancer treatment and must never replace prescribed aromatase inhibitors like anastrozole (Arimidex®), letrozole (Femara®), exemestane (Aromasin®), or historic agents like testolactone (Teslac®).
• At the same time, a body of evidence—from hormone measurements to meta-analyses—suggests that moderate coffee consumption is compatible with, and may even gently support, breast-cancer prevention and treatment, especially in postmenopausal women.
• Individual tolerance matters. For some people, caffeine worsens hot flushes, insomnia, reflux, or anxiety, and cutting back is clearly the right choice. For others, a cherished morning cup becomes part of a holistic survivorship plan that includes medication, movement, nutrition, and emotional support.

As always, the safest path is a conversational one: bring your coffee questions to your oncologist, breast-care nurse, or dietitian. They can help you weave together the science, your treatment plan, and your everyday routines so that your relationship with coffee feels less like a guilty secret and more like a thoughtfully chosen companion on the road through and beyond breast cancer.